Table 2. Summary of mean relative cerebral blood volume (relative-CBV).
| All Patients (n = 14) | CHS Group (n = 5) | Non-CHS Group (n = 9) | P-value (CHS vs non-CHS) | |
|---|---|---|---|---|
| ACA-terminal | ||||
| - Pre | 0.97 | 0.98 | 0.97 | 0.893 |
| - Intra | 0.94 | 0.94 | 0.94 | 0.986 |
| - %increase | −2.3% | −3.3% | −1.8% | 0.863 |
| P-value (Pre vs Intra) | 0.240 | 0.296 | 0.336 | |
| ACA-central | ||||
| - Pre | 0.88 | 0.88 | 0.88 | 0.998 |
| - Intra | 1.06 | 1.02 | 1.09 | 0.777 |
| - %increase | 33.2% | 41.7% | 28.5% | 0.802 |
| P-value (Pre vs Intra) | 0.152 | 0.293 | 0.206 | |
| MCA-terminal | ||||
| - Pre | 1.04 | 1.12 | 0.99 | 0.503 |
| - Intra | 1.05 | 1.32 | 0.90 | 0.152 |
| - %increase | 0.7% | 17.7% | −8.8% | 0.083 |
| P-value (Pre vs Intra) | 0.436 | 0.085 | 0.127 | |
| MCA-central | ||||
| - Pre | 0.99 | 1.09 | 0.93 | 0.417 |
| - Intra | 0.99 | 1.15 | 0.90 | 0.275 |
| - %increase | 1.5% | 8.1% | −2.2% | 0.460 |
| P-value (Pre vs Intra) | 0.493 | 0.308 | 0.318 | |
| PCA-terminal | ||||
| - Pre | 0.97 | 0.84 | 1.04 | 0.010* |
| - Intra | 0.97 | 1.00 | 0.95 | 0.472 |
| - %increase | 1.4% | 19.8% | –8.9% | 0.001* |
| P-value (Pre vs Intra) | 0.484 | 0.005* | 0.015* | |
*significant P-values after multiple comparison correction.